HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerosis obliterans.

AbstractBACKGROUND:
There is increasing evidence that immune processes are important in the development of atherosclerosis. We investigated whether low density lipoprotein (LDL) adsorption therapy affected serum cytokine levels and the expression of adhesion molecules on peripheral blood mononuclear cells (lymphocytes and monocytes) in patients with arteriosclerotic obliterance (ASO).
METHODS AND RESULTS:
LDL adsorption therapy was repeated ten times over a period of three months in ten ASO patients. The total serum cholesterol and LDL cholesterol levels were significantly reduced at the end of therapy. This was associated with a significant improvement in Fontaine's classification and ankle pressure index. We also measured serum levels of inflammatory cytokines (interleukin-1 beta (IL-1 beta), IL-6 and tissue necrosis factor alpha (TNF-alpha)) and expression of adhesion molecules (lymphocyte function-associated antigen 1 alpha (LFA-1 alpha), LFA-1 beta, CD2, very late antigen (VLA)-4, VLA-5 and CD44) on mononuclear cells in the same patients and a group of healthy subjects. Serum levels of all inflammatory cytokines were markedly higher in ASO patients compared with healthy subjects, but there was no significant difference in the level before and after LDL adsorption. VLA-4 expression on CD3+ cells, but not of other adhesion molecules, was markedly higher in ASO patients compared with healthy subjects. LDL adsorption caused a significant reduction in CD2, VLA4 and VLA-5 expression on CD3+ cells. Furthermore, VLA-4 and VLA-5 expression on monocytes diminished significantly after LDL adsorption.
CONCLUSIONS:
Our results indicate that LDL adsorption-induced immunoregulation is mediated by an indirect stimulatory effect on the immune system. The results suggests that improved peripheral circulation produced by LDL adsorption may reflect improved immune dysfunctions of atherosclerotic lesions in ASO patients.
AuthorsH Uno, Y Ueki, J Murashima, S Miyake, Y Tominaga, K Eguchi, K Yano
JournalAtherosclerosis (Atherosclerosis) Vol. 116 Issue 1 Pg. 93-102 (Jul 1995) ISSN: 0021-9150 [Print] Ireland
PMID7488336 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CD3 Complex
  • Cell Adhesion Molecules
  • Cytokines
  • Lipoproteins, LDL
Topics
  • Aged
  • Aged, 80 and over
  • Arteriosclerosis Obliterans (blood, complications, immunology, therapy)
  • CD3 Complex (analysis)
  • Cell Adhesion Molecules (metabolism)
  • Cytokines (blood)
  • Female
  • Hemoperfusion
  • Humans
  • Hyperlipidemias (blood, complications)
  • Leukocytes, Mononuclear (metabolism)
  • Lipoproteins, LDL (blood)
  • Lymphocyte Subsets (metabolism)
  • Male
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: